Leap Therapeutics Inc. (LPTX) Fundamentals

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205.
SHARE INFORMATION
Market Cap$ 116,580,359
Shares Outstanding88,318,454
Float69,400,220
Percent Float78.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,500,000
Latest Fiscal EPS$ -0.46
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions142
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months10,174,124
Institutional Holdings Percent80.6%
Institutional Sold Previous 3 Months1,635,116
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months1,785,000
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 4.17
52 Week Low$ 0.92
52 Week High Change$ -18.52
21 Day Moving Average$ 1.3178
21 Day Extended Moving Average$ 1.3195
50 Day Moving Average$ 1.5629
50 Day Extended Moving Average$ 1.5463
200 Day Moving Average$ 2.2247
200 Day Extended Moving Average$ 1.9949
10 Day Average Volume1,226,501
20 Day Average Volume871,750
30 Day Average Volume827,290
50 Day Average Volume766,234
Alpha-0.000807
Beta0.7209
Standard Deviation0.289275
R20.013915
7 Day Price Change$ 0.22
7 Day Percent Change20.0%
21 Day Price Change$ -0.07
21 Day Percent Change-5.04%
30 Day Price Change$ -0.27
30 Day Percent Change-16.98%
Month to Date Price Change$ 0.03
Month to Date Percent Change2.33%
Quarter to Date Price Change$ -0.43
Quarter to Date Percent Change-24.57%
180 Day Price Change$ -1.09
180 Day Percent Change-45.23%
200 Day Price Change$ -1.47
200 Day Percent Change-52.69%
Year to Date Price Change$ -1.92
Year to Date Percent Change-59.26%

Leap Therapeutics Inc. (LPTX) Key Ratios

PROFITABILITY
EBIT Margin-2,431.7%
EBITDA Margin-2,429.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,125,000
Revenue Per Share$ 0.0127
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.10
Total Debt To Equity0.00
Int Coverage-989.50
Current Ratio11.70
Leverage Ratio1.10
Quick Ratio11.60
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-2.80
Enterprise Value$ 1,250,174
Price to Sales103.627
Price to Free Cash-4.40
PE High Last 5 Years-1.50
Price To Book1.10
Price To Cash Flow0.00
PE Low Last 5 Years-1.60
Price to Tangible Book1.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.80
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-48.17
Return on Equity-53.65
Return on Capital-52.14

Leap Therapeutics Inc. (LPTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorEisnerAmper LLP
CEODouglas E. Onsi
Emplyoees36
Last AuditUQ
CIK0001509745
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address47 Thorndike Street
Suite B1-1
Cambridge, MA 2141
Websitehttps://www.leaptx.com
Facsimile-
Telephone+1 617 714-0360
Emaildonsi@leaptx.com
Your Recent History
NASDAQ
LPTX
Leap Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220518 08:57:16